Stay updated on Faricimab in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page
- ChecktodayChange DetectedPage revision updated to v3.6.6, indicating a small, behind-the-scenes update to the page template or metadata.SummaryDifference0.0%

- Check7 days agoChange DetectedAdded a new entry '2018 ( U.S. NIH Grant/Contract )' to the study's identifiers section, recording NIH funding associated with the trial. This update updates the funding disclosures reflected in the study's metadata.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's version details.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor version bump in the page's underlying documentation or tooling; no user-facing trial content or functionality appears to be altered.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3. This appears to be a minor update to the page’s metadata or content tracked in the site’s version history.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page shows a revision label updated from v3.6.0 to v3.6.2, signaling a newer revision of the study documents. This update does not alter the study details or how the page is used.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.